Cardiovascular

FDA recalls Alere diagnostic tests

On July 11, the U.S. Food and Drug Administration (FDA) announced the recall Alere Triage’s rapid diagnostic test system, which comprises a meter and various test devices that help diagnose such conditions as heart failure and myocardial infarction. The lots being recalled have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares